Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001569769-25-000002

COO and CFO acquired 53,361 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Soni Manmeet Singh · COO and CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-10-21 Grant or award : show line 1 in the form +53,361 $18.74 $999,985 3,073,603 D
Loading xslF345X05/wk-form4_1761250212.xml…